• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IRAK-4 死亡结构域的 N 端环调节 Myddosome 信号支架的有序组装。

The N-terminal loop of IRAK-4 death domain regulates ordered assembly of the Myddosome signalling scaffold.

机构信息

Department of Biochemistry, University of Cambridge, Cambridge, CB2 1GA, UK.

Molecular Discovery Research, GlaxoSmithKline R&D, Stevenage, SG1 2NY, UK.

出版信息

Sci Rep. 2016 Nov 23;6:37267. doi: 10.1038/srep37267.

DOI:10.1038/srep37267
PMID:27876844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5120336/
Abstract

Activation of Toll-like receptors induces dimerization and the recruitment of the death domain (DD) adaptor protein MyD88 into an oligomeric post receptor complex termed the Myddosome. The Myddosome is a hub for inflammatory and oncogenic signaling and has a hierarchical arrangement with 6-8 MyD88 molecules assembling with exactly 4 of IRAK-4 and 4 of IRAK-2. Here we show that a conserved motif in IRAK-4 (Ser8-X-X-X-Arg12) is autophosphorylated and that the phosphorylated DD is unable to form Myddosomes. Furthermore a mutant DD with the phospho-mimetic residue Asp at this position is impaired in both signalling and Myddosome assembly. IRAK-4 Arg12 is also essential for Myddosome assembly and signalling and we propose that phosphorylated Ser8 induces the N-terminal loop to fold into an α-helix. This conformer is stabilised by an electrostatic interaction between phospho-Ser8 and Arg12 and would destabilise a critical interface between IRAK-4 and MyD88. Interestingly IRAK-2 does not conserve this motif and has an alternative interface in the Myddosome that requires Arg67, a residue conserved in paralogues, IRAK-1 and 3(M).

摘要

Toll 样受体的激活诱导二聚体的形成,并将死亡结构域(DD)衔接蛋白 MyD88 募集到一个称为 Myddosome 的寡聚受体后复合物中。Myddosome 是炎症和致癌信号的中心,具有分层排列,其中 6-8 个 MyD88 分子与确切的 4 个 IRAK-4 和 4 个 IRAK-2 组装在一起。在这里,我们表明 IRAK-4 中的保守基序(Ser8-X-X-X-Arg12)发生自动磷酸化,并且磷酸化的 DD 无法形成 Myddosomes。此外,在该位置具有磷酸模拟残基 Asp 的突变 DD 在信号转导和 Myddosome 组装中均受到损害。IRAK-4 Arg12 对于 Myddosome 组装和信号转导也是必不可少的,我们提出磷酸化的 Ser8 诱导 N 端环折叠成α-螺旋。这种构象通过磷酸化 Ser8 和 Arg12 之间的静电相互作用得到稳定,并会破坏 IRAK-4 和 MyD88 之间的关键界面。有趣的是,IRAK-2 不保守此基序,并且在 Myddosome 中有一个替代界面,需要 Arg67,该残基在同源物 IRAK-1 和 3(M)中保守。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d62/5120336/18d625ed7ef1/srep37267-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d62/5120336/724a07ca7178/srep37267-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d62/5120336/c306a19d7e4f/srep37267-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d62/5120336/1b6ce693be37/srep37267-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d62/5120336/54c88cf59f53/srep37267-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d62/5120336/24f296e7bc7a/srep37267-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d62/5120336/2d324bb77df9/srep37267-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d62/5120336/18d625ed7ef1/srep37267-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d62/5120336/724a07ca7178/srep37267-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d62/5120336/c306a19d7e4f/srep37267-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d62/5120336/1b6ce693be37/srep37267-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d62/5120336/54c88cf59f53/srep37267-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d62/5120336/24f296e7bc7a/srep37267-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d62/5120336/2d324bb77df9/srep37267-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d62/5120336/18d625ed7ef1/srep37267-f7.jpg

相似文献

1
The N-terminal loop of IRAK-4 death domain regulates ordered assembly of the Myddosome signalling scaffold.IRAK-4 死亡结构域的 N 端环调节 Myddosome 信号支架的有序组装。
Sci Rep. 2016 Nov 23;6:37267. doi: 10.1038/srep37267.
2
MyD88 Death-Domain Oligomerization Determines Myddosome Architecture: Implications for Toll-like Receptor Signaling.MyD88 死亡结构域寡聚化决定了 Myddosome 结构:对 Toll 样受体信号转导的影响。
Structure. 2020 Mar 3;28(3):281-289.e3. doi: 10.1016/j.str.2020.01.003. Epub 2020 Jan 28.
3
Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a dual role in myddosome formation and Toll-like receptor signaling.白细胞介素-1 受体相关激酶 4(IRAK4)在 MyD88 衔接子复合物形成和 Toll 样受体信号通路中发挥双重作用。
J Biol Chem. 2018 Sep 28;293(39):15195-15207. doi: 10.1074/jbc.RA118.003314. Epub 2018 Aug 3.
4
An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4.由Toll样受体信号转导分子MyD88和IRAK-4形成的寡聚信号平台。
J Biol Chem. 2009 Sep 11;284(37):25404-11. doi: 10.1074/jbc.M109.022392. Epub 2009 Jul 10.
5
Understanding early TLR signaling through the Myddosome.通过 Myddosome 理解早期 TLR 信号转导。
J Leukoc Biol. 2019 Feb;105(2):339-351. doi: 10.1002/JLB.MR0318-096R. Epub 2018 Sep 26.
6
Contribution of globular death domains and unstructured linkers to MyD88.IRAK-4 heterodimer formation: an explanation for the antagonistic activity of MyD88s.球状死亡结构域和无结构连接子对MyD88.IRAK-4异二聚体形成的贡献:对MyD88s拮抗活性的一种解释
Biochem Biophys Res Commun. 2009 Feb 27;380(1):183-7. doi: 10.1016/j.bbrc.2009.01.069. Epub 2009 Jan 22.
7
Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling.TLR/IL-1R 信号转导中 MyD88-IRAK4-IRAK2 复合物的螺旋组装。
Nature. 2010 Jun 17;465(7300):885-90. doi: 10.1038/nature09121. Epub 2010 May 19.
8
IRAK4 dimerization and trans-autophosphorylation are induced by Myddosome assembly.IRAK4 二聚化和转磷酸化是由 Myddosome 组装诱导的。
Mol Cell. 2014 Sep 18;55(6):891-903. doi: 10.1016/j.molcel.2014.08.006. Epub 2014 Sep 4.
9
The IRAK-M death domain: a tale of three surfaces.白细胞介素-1受体相关激酶M死亡结构域:关于三个表面的故事
Front Mol Biosci. 2024 Jan 10;10:1265455. doi: 10.3389/fmolb.2023.1265455. eCollection 2023.
10
Biochemical Isolation of the Myddosome from Murine Macrophages.从小鼠巨噬细胞中进行Myddosome的生化分离。
Methods Mol Biol. 2018;1714:79-95. doi: 10.1007/978-1-4939-7519-8_6.

引用本文的文献

1
IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial.在化脓性汗腺炎和特应性皮炎中 IRAK4 降解剂:一项 1 期试验。
Nat Med. 2023 Dec;29(12):3127-3136. doi: 10.1038/s41591-023-02635-7. Epub 2023 Nov 13.
2
Role of innate immunological/inflammatory pathways in myelodysplastic syndromes and AML: a narrative review.先天性免疫/炎症途径在骨髓增生异常综合征和急性髓系白血病中的作用:一篇叙述性综述。
Exp Hematol Oncol. 2023 Jul 8;12(1):60. doi: 10.1186/s40164-023-00422-1.
3
IRAK3 modulates downstream innate immune signalling through its guanylate cyclase activity.

本文引用的文献

1
Activation of lymphoma-associated MyD88 mutations via allostery-induced TIR-domain oligomerization.通过变构诱导的TIR结构域寡聚化激活淋巴瘤相关的MyD88突变
Blood. 2014 Dec 18;124(26):3896-904. doi: 10.1182/blood-2014-05-573188. Epub 2014 Oct 30.
2
SMOCs: supramolecular organizing centres that control innate immunity.SMOCs:控制先天免疫的超分子组织中心。
Nat Rev Immunol. 2014 Dec;14(12):821-6. doi: 10.1038/nri3757. Epub 2014 Oct 31.
3
Molecular determinants of caspase-9 activation by the Apaf-1 apoptosome.凋亡蛋白酶激活因子-1凋亡小体对胱天蛋白酶-9激活的分子决定因素
IRAK3 通过其鸟苷酸环化酶活性调节下游先天免疫信号转导。
Sci Rep. 2019 Oct 29;9(1):15468. doi: 10.1038/s41598-019-51913-3.
4
Putative link between Polo-like kinases (PLKs) and Toll-like receptor (TLR) signaling in transformed and primary human immune cells.推测 Polo 样激酶 (PLKs) 与转化和原代人免疫细胞中的 Toll 样受体 (TLR) 信号之间的联系。
Sci Rep. 2019 Sep 11;9(1):13168. doi: 10.1038/s41598-019-49017-z.
5
Toll-like receptor 4: A promising therapeutic target for pneumonia caused by Gram-negative bacteria.Toll 样受体 4:革兰氏阴性菌引起肺炎的有前途的治疗靶点。
J Cell Mol Med. 2019 Sep;23(9):5868-5875. doi: 10.1111/jcmm.14529. Epub 2019 Jul 27.
6
Toll-like receptor 4 and protease-activated receptor 2 in physiology and pathophysiology of the nervous system: more than just receptor cooperation?Toll样受体4和蛋白酶激活受体2在神经系统生理与病理生理中的作用:不仅仅是受体协同作用?
Neural Regen Res. 2019 Jul;14(7):1196-1201. doi: 10.4103/1673-5374.251290.
7
Mechanism of dysfunction of human variants of the IRAK4 kinase and a role for its kinase activity in interleukin-1 receptor signaling.人类 IRAK4 激酶变体功能障碍的机制及其激酶活性在白细胞介素-1 受体信号转导中的作用。
J Biol Chem. 2018 Sep 28;293(39):15208-15220. doi: 10.1074/jbc.RA118.003831. Epub 2018 Aug 16.
8
Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a dual role in myddosome formation and Toll-like receptor signaling.白细胞介素-1 受体相关激酶 4(IRAK4)在 MyD88 衔接子复合物形成和 Toll 样受体信号通路中发挥双重作用。
J Biol Chem. 2018 Sep 28;293(39):15195-15207. doi: 10.1074/jbc.RA118.003314. Epub 2018 Aug 3.
9
Interleukin-1 Beta-A Friend or Foe in Malignancies?白细胞介素-1β在恶性肿瘤中是敌是友?
Int J Mol Sci. 2018 Jul 24;19(8):2155. doi: 10.3390/ijms19082155.
10
NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy.淋巴恶性肿瘤中的核因子-κB激活:遗传学、信号传导与靶向治疗
Biomedicines. 2018 Mar 26;6(2):38. doi: 10.3390/biomedicines6020038.
Proc Natl Acad Sci U S A. 2014 Nov 18;111(46):16254-61. doi: 10.1073/pnas.1418000111. Epub 2014 Oct 13.
4
IRAK4 dimerization and trans-autophosphorylation are induced by Myddosome assembly.IRAK4 二聚化和转磷酸化是由 Myddosome 组装诱导的。
Mol Cell. 2014 Sep 18;55(6):891-903. doi: 10.1016/j.molcel.2014.08.006. Epub 2014 Sep 4.
5
Assembly and localization of Toll-like receptor signalling complexes.Toll 样受体信号复合物的组装和定位。
Nat Rev Immunol. 2014 Aug;14(8):546-58. doi: 10.1038/nri3713.
6
Functional assessment of the mutational effects of human IRAK4 and MyD88 genes.人类 IRAK4 和 MyD88 基因的突变效应的功能评估。
Mol Immunol. 2014 Mar;58(1):66-76. doi: 10.1016/j.molimm.2013.11.008. Epub 2013 Dec 5.
7
The IRAK homolog Pelle is the functional counterpart of IκB kinase in the Drosophila Toll pathway.IRA激酶同源物 Pelle 是果蝇 Toll 途径中 IκB 激酶的功能对应物。
PLoS One. 2013 Sep 23;8(9):e75150. doi: 10.1371/journal.pone.0075150. eCollection 2013.
8
IRAK-M mediates Toll-like receptor/IL-1R-induced NFκB activation and cytokine production.IRAK-M 介导 Toll 样受体/IL-1R 诱导的 NFκB 激活和细胞因子产生。
EMBO J. 2013 Feb 20;32(4):583-96. doi: 10.1038/emboj.2013.2. Epub 2013 Feb 1.
9
Helical assembly in the death domain (DD) superfamily.螺旋组装在死亡域(DD)超家族中。
Curr Opin Struct Biol. 2012 Apr;22(2):241-7. doi: 10.1016/j.sbi.2012.02.006. Epub 2012 Mar 17.
10
The extended cleavage specificity of human thrombin.人凝血酶的扩展裂解特异性。
PLoS One. 2012;7(2):e31756. doi: 10.1371/journal.pone.0031756. Epub 2012 Feb 27.